Ocean Biomedical Stock (NASDAQ: OCEA) stock price, news, charts, stock research, profile.
Open | $1.260 |
Close | $1.340 |
Volume / Avg. | 248.221K / 6.699M |
Day Range | 1.260 - 1.427 |
52 Wk Range | 0.520 - 12.080 |
Market Cap | $48.162M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 9.17% |
Days to Cover | 1.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocean Biomedical (NASDAQ: OCEA) through any online brokerage.
Other companies in Ocean Biomedical’s space includes: NKGen Biotech (NASDAQ:NKGN), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Ocean Biomedical (NASDAQ: OCEA) was reported by Taglich Brothers on Wednesday, May 31, 2023. The analyst firm set a price target for 20.00 expecting OCEA to rise to within 12 months (a possible 1338.85% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ocean Biomedical (NASDAQ: OCEA) is $1.39 last updated April 26, 2024 at 7:43 PM EDT.
There are no upcoming dividends for Ocean Biomedical.
Ocean Biomedical’s Q4 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Ocean Biomedical.
Ocean Biomedical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.